Bob Patterson
Analyst · Goldman Sachs. Your line is now open
Well, thank you, Joe. And good morning, everyone. We have record results to share today, as well as increased optimism for the rest of the year, as demand conditions are stronger than previously expected. While the world still has a long way to go with respect to combating COVID-19, we are optimistic that as an increasing percentage of the world's population receives the vaccination, this too will help drive demand. We start today and begin by reviewing our results for Q1, where we achieved the highest level of organic sales growth in the last 10 years. Certainly, we're benefiting from a pandemic recovery but our results are also a result of many things and a lot of hard work. Our performance is underpinned by the investments we have made to transform our portfolio to one that is more specialized, focused on sustainable solutions and concentrated high growth end markets. And our team delivered these results despite supply chain disruptions that have impacted most everyone in the industry. We thank our suppliers and our own supply chain leaders for exemplary work to make this possible. I'm also pleased we were able to expand operating margins by 200 basis points during a period of inflation by being on top of pricing, capturing synergies, ahead of schedule and an improving mix of product sales. And this is all translated to adjusted operating income growth 43% and adjusted EPS growth of 68%. All three of our business segments contributed to our success, each delivering record revenue and operating income for the quarter. Our core business grew operating income 39% due to robust demand for consumer applications as well as sustainable solutions. We're also benefiting from early synergy capture related to the Clariant Masterbatch acquisition. Specialty engineering materials expanded operating income 55% driven by continued strength and sales of our composite technologies, as well as new business gains in healthcare and consumer applications. And last but certainly not least, our distribution segment delivered record operating income of $24 million, an increase of 26% over the prior year. This was led by strong demand in new business causes in healthcare and consumer. Truly outstanding performance by all of our segments to begin the year. It's an understatement to say that we have been investing in sustainable solutions and new technologies such as composites that serve high growth end markets. Over the years, our portfolio has undergone a tremendous and deliberate transformation with an increased focus on specialty applications. Not only has this been an important contributor to our recent growth, but the benefits of improved mix are clearly driving higher margins despite raw material inflation. For investors who followed us in our early years, you know margin expansion was a hallmark of our success. Now as Avient, it is and will be again. When we announced the acquisition of Clariant Masterbatch, there were some questions regarding our ability to improve the margins to the level of the legacy PolyOne color business. I'm pleased to report that in the first nine months of ownership, we have made significant progress in this regard, while also seeing an uptick in legacy PolyOne margins. For the legacy Clariant business, we have expanded EBITDA margins from 11.9% to 17.4%. I have to say there is so much energy and excitement that has been generated from the combined organizations even in this primarily virtual environment. I've seen a number of integration efforts over the years, and couldn't be more proud of how we have come together culturally and operationally for each other and our customers. As our teams continue to work together, we have been able to accelerate our synergy capture, and realized $11 million in the first quarter. And in addition, we expect the full year realization to be $45 million, up from our previous estimate of $35 million a few months ago. During our February webcast, we provided a bridge and the key drivers behind our 2021 growth projections, which included sustainable solutions, healthcare, composites and growth outside the U.S. and emerging regions. We've updated this bridge for Q1 performance, and you can see how these drivers contributed to our first quarter results. And these are the same areas that you will continue to hear us refer to when discussing our ability to grow in excess of the market over the long term. From an end market perspective, our largest segments, which are tied to long term growth platforms performed exceptionally well during the quarter. In particular, healthcare and consumer applications lead the way with 22% and 24% growth respectively. You may look at packaging and question its relative performance, but don't. This simply reflects how well packaging did in the early days of the pandemic last year, and specifically in Asia, which was impacted most in Q1 in 2020. The health of our focused end markets are a big reason, we are delivering record levels of revenue and operating income. Combined with the optimism from the ongoing vaccine rollout, it gives us growing confidence in the economy and our ability to deliver. So, as you read in our news release this morning, we have increased our outlook for the year which Jamie will now cover as part of her remarks. Jamie?